Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)

Market Cap	13.05B
Revenue (ttm)	2.38B
Net Income (ttm)	560.50M
Shares Out	530.03M
EPS (ttm)	1.06
PE Ratio	23.31
Forward PE	n/a
Dividend	0.38 (1.53%)
Ex-Dividend Date	Jan 24, 2025

Volume	1,809,800
Average Volume	2,437,212
Open	24.65
Previous Close	24.63
Day's Range	23.97 - 24.71
52-Week Range	18.07 - 26.90
Beta	0.75
RSI	52.35
Earnings Date	Aug 29, 2025

About SHE:002287

Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China. The company also provides plasters and ointments. Its products are used in areas of orthopedics, neurology, dermatology, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, and cerebrovascular sectors. The company was founded in 1995 and is based in Nyingchi, China. Tibet Cheezheng Tibetan Medicine Co., Ltd. is a subsidiary of Gansu Qizheng Industry Group Co., Ltd.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 3,091
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002287

Financial Performance

In 2024, SHE:002287's revenue was 2.34 billion, an increase of 14.32% compared to the previous year's 2.05 billion. Earnings were 582.28 million, an increase of 0.19%.